According to a new report, published by KBV research, The Global Atrial Fibrillation Market size is expected to reach $2.7 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.
The Specialty Clinics market is exhibiting a CAGR of 6.6% during (2022 - 2028). It is due to factors such as the desire for a more convenient solution to hospital-based outpatient treatments, the rise in demand for same-day surgical care in outpatient settings, and the availability of cost-effective services. The majority of patients can be discharged the same day if they are clinically stable after catheter ablation of atrial fibrillation, which can be done effectively on the same day of admission with little risk of complications.
The Surgical market segment shows high market share in the Global Atrial Fibrillation Market by Type in 2021; thereby, achieving a market value of $1.6 billion by 2028. It is because the process of ablation is used to cure atrial fibrillation. To help break up the electrical signals that result in irregular heartbeats, it uses small sunburns or freezes to induce some scarring on the inside of the heart. This may aid in keeping the heart's beat regular. 4 chambers make up the heart. There are two ventricles and two atria, which are the upper and lower chambers, respectively.
The Laser market is anticipated to grow at a CAGR of 6.3% during (2022 - 2028). The efferent end of a fiber-optic cable that is 60 degrees off the axis is housed in a handpiece made of plastic that has been specially shaped. The tip is made of a tiny plastic nipple with a distal concavity that, despite being superficial to the epicardium, permits saline injection at the point where the laser exits the device. This layer of saline enables uniform laser energy transmission through the endocardium and transmurally to the atrial epicardium.
The North America market dominated the Global Atrial Fibrillation Market by Region in 2021; thereby, achieving a market value of $923 million by 2028. The Europe market would witness a CAGR of 5.4% during (2022 - 2028). Additionally, The Asia Pacific market is experiencing a CAGR of 7% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/atrial-fibrillation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG) and AtriCure, Inc.
By End User
By Type
By Technology
By Geography
Companies Profiled
Unique Offerings 
